| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita 879-5593, Japan
Address all correspondence and requests for reprints to: Dr. Masakazu Nishida, Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Hasama-machi, Oita 879-5593, Japan. E-mail: nishida{at}med.oita-u.ac.jp.
To evaluate the involvement of chemokines in the pathogenesis of endometriosis, we investigated the expression of CXC chemokines in cultured ovarian endometriotic cyst stromal cells (ECSC), endometrial stromal cells with endometriosis (ESCwE), and normal endometrial stromal cells (NESC). Using ELISA, TNF-
significantly enhanced the production of IL-8, growth-related oncogene
, and epithelial neutrophil-activating peptide-78 in all cases of ECSC (n = 10), ESCwE (n = 6), and, NESC (n = 10). IL-1ß did not affect the production of these chemokines in eight of 10 cases of ECSC. In contrast, IL-1ß significantly enhanced the expression of these chemokines in all cases of ESCwE (n = 6) and NESC (n = 10). Western blot analysis revealed down-regulation of expression of IL-1 receptor type 1 (IL-1-R1) in all cases of ECSC with low response to IL-1ß (n = 8). In contrast, significant IL-1-R1 expression was detected in all cases of NESC. Although IL-1-R1 expression was detected in all cases of ESCwE (n = 6), its expression in ESCwE tended to decrease compared with that in NESC. Moreover, phosphorylation of inhibitor
B-
was detected in all cases of ESCwE and NESC after stimulation with IL-1ß, but not in ECSC with low response to IL-1ß (n = 8). In contrast, significant IL-1-R2 expression was detected in all cases of ECSC, ESCwE, and NESC. The present findings suggest that the dysregulation of IL-1/IL-1-R system relates to immunological dysfunction in endometriosis. The alteration of the CXC chemokines expression may be important for elucidation of the pathogenesis of endometriosis.
This article has been cited by other articles:
![]() |
A. Tsuno, K. Nasu, A. Yuge, H. Matsumoto, M. Nishida, and H. Narahara Decidualization Attenuates the Contractility of Eutopic and Ectopic Endometrial Stromal Cells: Implications for Hormone Therapy of Endometriosis J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2516 - 2523. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, R. J. Belton Jr., and R. A. Nowak Basigin-Mediated Gene Expression Changes in Mouse Uterine Stromal Cells During Implantation Endocrinology, February 1, 2009; 150(2): 966 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nasu, M. Nishida, T. Ueda, A. Yuge, N. Takai, and H. Narahara Application of the nuclear factor-{kappa}B inhibitor BAY 11-7085 for the treatment of endometriosis: an in vitro study Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E16 - E23. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yuge, K. Nasu, H. Matsumoto, M. Nishida, and H. Narahara Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis-associated fibrosis Hum. Reprod., April 1, 2007; 22(4): 938 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishida, K. Nasu, T. Ueda, A. Yuge, N. Takai, and H. Narahara beta-Hydroxyisovalerylshikonin induces apoptosis and G0/G1 cell-cycle arrest of endometriotic stromal cells: a preliminary in vitro study Hum. Reprod., November 1, 2006; 21(11): 2850 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nasu, M. Nishida, T. Ueda, N. Takai, S. Bing, H. Narahara, and I. Miyakawa Bufalin induces apoptosis and the G0/G1 cell cycle arrest of endometriotic stromal cells: a promising agent for the treatment of endometriosis Mol. Hum. Reprod., November 1, 2005; 11(11): 817 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishida, K. Nasu, T. Ueda, J. Fukuda, N. Takai, and I. Miyakawa Endometriotic cells are resistant to interferon-{gamma}-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis Mol. Hum. Reprod., January 1, 2005; 11(1): 29 - 34. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |